Published in J Virol on October 10, 2012
The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis. Microbiol Mol Biol Rev (2013) 0.93
Crucial role of PA in virus life cycle and host adaptation of influenza A virus. Med Microbiol Immunol (2014) 0.80
CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection. J Virol (2013) 0.80
Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication. PLoS One (2015) 0.77
Generation and Comprehensive Analysis of Host Cell Interactome of the PA Protein of the Highly Pathogenic H5N1 Avian Influenza Virus in Mammalian Cells. Front Microbiol (2017) 0.75
Phenotypic and Genetic Characterization of Avian Influenza H5N2 Viruses with Intra- and Inter-Duck Variations in Taiwan. PLoS One (2015) 0.75
Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics (1996) 24.62
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
A sequence motif in many polymerases. Nucleic Acids Res (1988) 5.33
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature (2009) 5.06
Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol (1975) 4.89
Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature (2009) 4.49
The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol (2008) 4.33
A plasmid-based reverse genetics system for influenza A virus. J Virol (1996) 4.33
Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology (1987) 3.53
A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J Virol (2002) 3.37
Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog (2008) 3.37
Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat Struct Mol Biol (2007) 3.13
Influenza A viruses: new research developments. Nat Rev Microbiol (2011) 3.00
Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1. J Virol (1994) 2.98
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76
The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J (2001) 2.52
The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J Virol (1997) 2.51
Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J (2003) 2.38
Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol (2001) 2.33
Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J Biol Chem (2002) 2.31
The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J Virol (2004) 2.30
Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol (2008) 2.29
Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res (2007) 2.21
Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J Biol Chem (2003) 2.15
Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit. J Gen Virol (1994) 2.03
Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol (1995) 2.02
Intracellular localization of the viral polymerase proteins in cells infected with influenza virus and cells expressing PB1 protein from cloned cDNA. J Virol (1987) 2.02
Pandemic influenza: an inconvenient mutation. Science (2009) 2.00
HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol (1997) 1.98
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
Two signals mediate nuclear localization of influenza virus (A/WSN/33) polymerase basic protein 2. J Virol (1991) 1.95
Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. J Virol (2006) 1.93
Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J Virol (2006) 1.93
Function of two discrete regions is required for nuclear localization of polymerase basic protein 1 of A/WSN/33 influenza virus (H1 N1). Mol Cell Biol (1990) 1.89
In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex. J Virol (2005) 1.73
bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J Virol (1996) 1.69
The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol (2000) 1.69
Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase. Genes Cells (1999) 1.67
The RNA polymerase of influenza a virus is stabilized by interaction with its viral RNA promoter. J Virol (2002) 1.66
K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol (2002) 1.65
Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun (2011) 1.65
Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics (2008) 1.64
Precise large deletions by the PCR-based overlap extension method. Mol Biotechnol (1995) 1.60
Nuclear transport of influenza virus polymerase PA protein. Virus Res (1992) 1.59
Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res (1989) 1.49
Nuclear location of all three influenza polymerase proteins and a nuclear signal in polymerase PB2. EMBO J (1986) 1.48
Influenza virus virulence and its molecular determinants. Adv Virus Res (2005) 1.44
De novo replication of the influenza virus RNA genome is regulated by DNA replicative helicase, MCM. EMBO J (2007) 1.38
Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site. Genes Cells (2001) 1.35
Detection and characterization of influenza A virus PA-PB2 interaction through a bimolecular fluorescence complementation assay. J Virol (2009) 1.30
Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J Virol (2000) 1.28
Host factors for replication and transcription of the influenza virus genome. Rev Med Virol (2008) 1.27
Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol (2004) 1.25
The transcription/replication activity of the polymerase of influenza A viruses is not correlated with the level of proteolysis induced by the PA subunit. Virology (2001) 1.24
Human-like PB2 627K influenza virus polymerase activity is regulated by importin-α1 and -α7. PLoS Pathog (2012) 1.24
Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy. J Virol (2009) 1.23
Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication. J Virol (2009) 1.17
Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J Gen Virol (2001) 1.16
Interaction of the influenza A virus polymerase PB2 C-terminal region with importin alpha isoforms provides insights into host adaptation and polymerase assembly. J Biol Chem (2011) 1.11
Molecular mapping of influenza virus RNA polymerase by site-specific antibodies. Virology (1999) 1.09
Differential role of the influenza A virus polymerase PA subunit for vRNA and cRNA promoter binding. Virology (2007) 1.09
Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol (2005) 1.08
A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase promotes the generation of defective interfering RNAs. J Virol (2003) 1.08
Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication. J Biol Chem (2009) 1.07
Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies. Virology (2009) 1.01
Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors. J Virol (2011) 0.99
HAX-1: a family of apoptotic regulators in health and disease. J Cell Physiol (2011) 0.92
Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5. J Gen Virol (2011) 0.91
Molecular interaction between HAX-1 and XIAP inhibits apoptosis. Biochem Biophys Res Commun (2010) 0.87
Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability. Carcinogenesis (2009) 0.85
An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization. J Cell Physiol (2008) 0.83
Requirement for Siva-1 for replication of influenza A virus through apoptosis induction. J Gen Virol (2010) 0.83
SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu. Cancer Res (2006) 0.79
SV40 T/t-common polypeptide enhances the sensitivity of HER2-overexpressing human cancer cells to anticancer drugs cisplatin and doxorubicin. Cancer Lett (2012) 0.78
SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer. Cancer Gene Ther (2011) 0.76
Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol (2008) 7.37
Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science (2002) 3.60
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (2004) 2.74
Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med (2007) 2.56
Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc (2009) 2.28
Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol Cell (2011) 1.94
Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics (2009) 1.85
Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology (2010) 1.78
High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother (2003) 1.75
The telomerase-recruitment domain of the telomere binding protein Cdc13 is regulated by Mec1p/Tel1p-dependent phosphorylation. Nucleic Acids Res (2006) 1.71
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis (2013) 1.70
Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology (2007) 1.70
Epidemiology and impacts of children hospitalized with pneumonia from 1997 to 2004 in Taiwan. Pediatr Pulmonol (2009) 1.62
Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J Med Virol (2002) 1.57
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine (2002) 1.56
Fatal coxsackievirus A16 infection. Pediatr Infect Dis J (2004) 1.55
Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52
Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniae. Crit Care Med (2008) 1.50
Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res (2006) 1.50
SARS in hospital emergency room. Emerg Infect Dis (2004) 1.44
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis (2008) 1.43
Influenza pandemics: past, present and future. J Formos Med Assoc (2006) 1.41
Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J (2007) 1.39
Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet (2012) 1.39
Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene (2004) 1.38
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet (2012) 1.30
Community-acquired methicillin-resistant Staphylococcus aureus in children in northern Taiwan. J Microbiol Immunol Infect (2004) 1.26
Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1. J Biol Chem (2005) 1.24
Involvement of replicative polymerases, Tel1p, Mec1p, Cdc13p, and the Ku complex in telomere-telomere recombination. Mol Cell Biol (2002) 1.23
Community outbreak of adenovirus, Taiwan, 2011. Emerg Infect Dis (2012) 1.17
Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect (2011) 1.16
Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect (2004) 1.16
Role of RsmA in the regulation of swarming motility and virulence factor expression in Proteus mirabilis. J Med Microbiol (2003) 1.16
A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005. J Med Virol (2008) 1.15
Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics (2004) 1.15
c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair. J Biol Chem (2003) 1.14
Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J Med Virol (2007) 1.14
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine (2009) 1.12
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults. Hum Vaccin (2011) 1.12
Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis (2004) 1.12
Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect (2011) 1.12
Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J Virol (2008) 1.11
Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan, 2010-2011. PLoS One (2013) 1.11
Influenza in Taiwan: seasonality and vaccine strain match. J Microbiol Immunol Infect (2005) 1.10
Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS One (2011) 1.10
Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis (2004) 1.09
Modulation of swarming and virulence by fatty acids through the RsbA protein in Proteus mirabilis. Infect Immun (2004) 1.08
Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study. PLoS One (2011) 1.08
Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol (2005) 1.08
Nutritionally variant streptococcal infections at a University Hospital in Taiwan: disease emergence and high prevalence of beta-lactam and macrolide resistance. Clin Infect Dis (2004) 1.06
Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid. BMC Cancer (2010) 1.05
Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells. Stem Cells (2010) 1.03
Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol (2007) 1.03
Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr (2007) 1.03
Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study. Virol J (2013) 1.02
Involvement of topoisomerase III in telomere-telomere recombination. J Biol Chem (2006) 1.02
Rapid Cdc13 turnover and telomere length homeostasis are controlled by Cdk1-mediated phosphorylation of Cdc13. Nucleic Acids Res (2009) 1.01
Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res (2006) 1.01
Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicrob Agents (2007) 1.01
Coxsackieviruses infection in northern Taiwan--epidemiology and clinical characteristics. J Microbiol Immunol Infect (2009) 1.01
Four-year follow-up of the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10-14 years. J Adolesc Health (2012) 1.01
An outbreak of coxsackievirus A16 infection: comparison with other enteroviruses in a preschool in Taipei. J Microbiol Immunol Infect (2010) 1.00
Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics (2008) 0.99
Serotype competence and penicillin resistance in Streptococcus pneumoniae. Emerg Infect Dis (2006) 0.99
Necrotizing pneumococcal pneumonia in children: the role of pulmonary gangrene. Pediatr Pulmonol (2006) 0.99
Microbiology and epidemiology of brain abscess and subdural empyema in a medical center: a 10-year experience. J Microbiol Immunol Infect (2009) 0.99
Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus. FEBS Lett (2004) 0.99
Extrachromosomal telomeric circles contribute to Rad52-, Rad50-, and polymerase delta-mediated telomere-telomere recombination in Saccharomyces cerevisiae. Eukaryot Cell (2005) 0.99
Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis. J Microbiol Immunol Infect (2006) 0.98
Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001-2005 -- seasonality, clinical characteristics, and disease burden. J Microbiol Immunol Infect (2007) 0.98
Sumoylation of the BLM ortholog, Sgs1, promotes telomere-telomere recombination in budding yeast. Nucleic Acids Res (2009) 0.98
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girls. J Adolesc Health (2010) 0.97
Epidemic pleurodynia caused by coxsackievirus B3 at a medical center in northern Taiwan. J Microbiol Immunol Infect (2010) 0.97
Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence. Antimicrob Agents Chemother (2010) 0.97
Chromobacterium violaceum infection in children: a case of fatal septicemia with nasopharyngeal abscess and literature review. Pediatr Infect Dis J (2002) 0.97
Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan. Pediatr Pulmonol (2012) 0.97
Interaction between HSP60 and beta-catenin promotes metastasis. Carcinogenesis (2009) 0.96
Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Vaccine (2010) 0.96
Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine (2011) 0.95
Clinical management and outcome of childhood lung abscess: a 16-year experience. J Microbiol Immunol Infect (2005) 0.95
The chinese herbal medicine Tien-Hsien liquid inhibits cell growth and induces apoptosis in a wide variety of human cancer cells. J Altern Complement Med (2005) 0.95
Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J Biol Chem (2005) 0.95
Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS One (2012) 0.95
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics (2009) 0.94
Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine. J Virol Methods (2012) 0.93
Rice SUVH histone methyltransferase genes display specific functions in chromatin modification and retrotransposon repression. Mol Plant (2010) 0.93
Activation of phosphoinositide 3-kinase by the NBS1 DNA repair protein through a novel activation motif. J Mol Med (Berl) (2008) 0.93
Successful treatment of Candida tropicalis arthritis, osteomyelitis and costochondritis with caspofungin and fluconazole in a recipient of bone marrow transplantation. Acta Paediatr (2006) 0.92
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator. Genome Biol (2014) 0.92
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza. Vaccine (2010) 0.91
Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis (2005) 0.90
Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients. J Microbiol Immunol Infect (2007) 0.90
Immunomodulating effects of "tien-hsien liquid" on peripheral blood mononuclear cells and T-lymphocytes from patients with recurrent aphthous ulcerations. Am J Chin Med (2004) 0.90
Molecular and clinical characteristics of adenoviral infections in Taiwanese children in 2004-2005. Eur J Pediatr (2007) 0.90
Household transmission of Pandemic (H1N1) 2009 Virus, Taiwan. Emerg Infect Dis (2011) 0.89
Clinical features and factors of unfavorable outcomes for non-polio enterovirus infection of the central nervous system in northern Taiwan, 1994-2003. J Microbiol Immunol Infect (2005) 0.89
Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981. J Formos Med Assoc (2007) 0.89
The epidemiology of hospitalized children with pneumococcal/lobar pneumonia and empyema from 1997 to 2004 in Taiwan. Eur J Pediatr (2010) 0.89